Uroxatral (Concordia Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Uroxatral drug offered from Concordia Pharmaceuticals Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Concordia Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Alfuzosin HCl |
| SUBSTANCE NAME: | ALFUZOSIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-06-03 |
| END MARKETING DATE: | 0000-00-00 |
Uroxatral HUMAN PRESCRIPTION DRUG Details:
| Item Description | Uroxatral from Concordia Pharmaceuticals Inc. |
| LABELER NAME: | Concordia Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2013-06-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59212-200_9e101325-c980-461b-b781-190cc622fccf |
| PRODUCT NDC: | 59212-200 |
| APPLICATION NUMBER: | NDA021287 |
Other ALFUZOSIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
